Cholesterol-linked drug boosts gene-targeting potency in early findings
Image: Phys.org
ad slot · in-content video 16:9
Coverage
More coverage
- Nucleic acid therapeutics, such as antisense oligonucleotides (ASOs), have emerged as promising platforms for treating a variety of previously hard-to-treat diseases, including neurological diseases.